C. Webster Andrews

3.5k citations

33 papers · 2.7k indexed · 1 hit paper · h-index 19

Molecular Biology top 5%
Organic Chemistry top 2%
Computational Theory and Mathematics top 0.5%
Infectious Diseases top 5%
Materials Chemistry

Co-authors: Bert Fraser‐Reid J. Phillip Bowen Mika Lindvall Martha S. Head Brian Clarke Gregory L. Warren Catherine E. Peishoff Giovanna Tedesco
Topics: HIV/AIDS drug development and treatment (8 papers)Carbohydrate Chemistry and Synthesis (7 papers)Enzyme Catalysis and Immobilization (5 papers)
Cited by: Computational Theory and Mathematics Virology Organic Chemistry
Journals: Journal of the American Chemical Society Journal of Biological Chemistry Biochemical and Biophysical Research Communications
Partner nations: United States United Kingdom Italy

In The Last Decade

C. Webster Andrews

33 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Critical Assessment of Docking Programs and Scoring Functions

2005 1.3k citations C. Webster Andrews et al. Journal of Medicinal Chemistry profile →

Peers

Countries citing papers authored by C. Webster Andrews

Since Specialization

Citations

This map shows the geographic impact of C. Webster Andrews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Webster Andrews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Webster Andrews more than expected).

Fields of papers citing papers by C. Webster Andrews

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Webster Andrews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Webster Andrews. The network helps show where C. Webster Andrews may publish in the future.

Co-authorship network of co-authors of C. Webster Andrews

This figure shows the co-authorship network connecting the top 25 collaborators of C. Webster Andrews. A scholar is included among the top collaborators of C. Webster Andrews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Webster Andrews. C. Webster Andrews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Imidazo[5,1-f][1,2,4]triazin-2-amines as novel inhibitors of polo-like kinase 1 2008 ·Bioorganic & Medicinal Chemistry Letters ·Mui Cheung,Kevin W. Kuntz,(unknown),James M. Salovich,Bart J. Wilson,C. Webster Andrews,Lisa M. Shewchuk,Andrea H. Epperly,Daniel F. Hassler,M. Anthony Leesnitzer,Jeffery L. Smith,Gail K. Smith,Timothy J. Lansing,Robert A. Mook	9
2	Structural Basis for the Improved Drug Resistance Profile of New Generation Benzophenone Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors 2008 ·Journal of Medicinal Chemistry ·Jingshan Ren,Philip P. Chamberlain,Anna Stamp,Steven A. Short,Kurt Weaver,Karen R. Romines,Richard Hazen,Andrew Freeman,Robert G. Ferris,C. Webster Andrews,Lawrence R. Boone,Joseph H. Chan,D.K. Stammers	64
3	Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: The discovery of GW0385 2006 ·Bioorganic & Medicinal Chemistry Letters ·John F. Miller,C. Webster Andrews,(unknown),Eric S. Furfine,Michael Hale,Mary H. Hanlon,Richard Hazen,István Káldor,Ed W. McLean,David J. Reynolds,(unknown),Andrew Spaltenstein,Roger D. Tung,Elizabeth M. Turner,Robert X. Xu,Ronald G. Sherrill	70
4	Optimization of pyrrolidinone based HIV protease inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·Ronald G. Sherrill,C. Webster Andrews,(unknown),Ronda G. Davis‐Ward,Eric S. Furfine,Richard Hazen,(unknown),Andrew Spaltenstein,Lois L. Wright	10
5	Novel Benzophenones as Non-nucleoside Reverse Transcriptase Inhibitors of HIV-1 2004 ·Journal of Medicinal Chemistry ·Joseph H. Chan,George A. Freeman,Jeffrey H. Tidwell,Karen R. Romines,Lee T. Schaller,Jill R. Cowan,(unknown),(unknown),C. Webster Andrews,David J. Reynolds,Marty St. Clair,Richard Hazen,(unknown),Katrina L. Creech,(unknown),Steven A. Short,Kurt Weaver,George W. Koszalka,Lawrence R. Boone	52
6	Predicting Human Oral Bioavailability of a Compound: Development of a Novel Quantitative Structure-Bioavailability Relationship 2000 ·Pharmaceutical Research ·C. Webster Andrews,L. Michelle Bennett,Lawrence X. Yu	98
7	Conformation and Local Environment of Nucleotides Bound To Hiv Type 1 Reverse Transcriptase (HIV-1 RT) in The Ground State 2000 ·Nucleosides Nucleotides & Nucleic Acids ·George R. Painter,C. Webster Andrews,Phillip A. Furman	14
8	The isolation and structure determination of cryptomisrine, a novel indolo[3,2‐b]quinoline dimeric alkaloid from cryptolepis sanguinolenta 1996 ·Journal of Heterocyclic Chemistry ·Maged H. M. Sharaf,Paul L. Schiff,Albert N. Tackie,Charles H. Phoebe,Robert L. Johnson,(unknown),Ronald C. Crouch,Gary E. Martin,C. Webster Andrews	39
9	4-(Heteroarylthio)-2-biphenylyltetrazoles as Nonpeptide Angiotensin II Antagonists 1995 ·Journal of Medicinal Chemistry ·Mark H. Norman,(unknown),C. Webster Andrews,Flora Tang,Conrad L. Cowan,R. Steffen	7
10	Isolation and elucidation of the structure of homocryptolepinone 1995 ·Journal of Heterocyclic Chemistry ·Maged H. M. Sharaf,Paul L. Schiff,Albert N. Tackie,Charles H. Phoebe,(unknown),C. Webster Andrews,Ronald C. Crouch,Gary E. Martin	16
11	Iteratively reweighted partial least squares: A performance analysis by monte carlo simulation 1995 ·Journal of Chemometrics ·David J. Cummins,C. Webster Andrews	80
12	¹⁵N chemical shifts and long‐range ¹H‐¹⁵N coupling pathways of selected strychnos alkaloids 1995 ·Journal of Heterocyclic Chemistry ·Gary E. Martin,Ronald C. Crouch,C. Webster Andrews	17
13	Submicromole structure elucidation: Cryptolepicarboline—a novel dimeric alkaloid from Cryptolepis sanguinolenta 1995 ·Magnetic Resonance in Chemistry ·Maged H. M. Sharaf,Paul L. Schiff,Albert N. Tackie,Charles H. Phoebe,(unknown),(unknown),Chad E. Hadden,(unknown),(unknown),C. Webster Andrews,(unknown),Robert L. Johnson,John P. Shockcor,Ronald C. Crouch,Gary E. Martin	23
14	A Comparison of the Conformations of the 5′-Triphosphates of Zidovudine (AZT) and Thymidine Bound to HIV-1 Reverse Transcriptase 1993 ·Biochemical and Biophysical Research Communications ·George R. Painter,Ann Aulabaugh,C. Webster Andrews	31
15	The chemistry of N-pentenyl glycosides: Synthetic, theoretical, and mechanistic ramifications 1993 ·Pure and Applied Chemistry ·Bert Fraser‐Reid,J. Robert Merritt,Anthony L. Handlon,C. Webster Andrews	22
16	Molecular mechanical investigations of the properties of oxocarbenium ions. 2. Application to glycoside hydrolysis 1992 ·Journal of the American Chemical Society ·Robert J. Woods,C. Webster Andrews,J. Phillip Bowen	80
17	2-[(Arylmethyl)amino]-2-methyl-1,3-propanediol DNA intercalators. An examination of the effects of aromatic ring variation on antitumor activity and DNA binding 1991 ·Journal of Medicinal Chemistry ·Kenneth W. Bair,C. Webster Andrews,Richard L. Tuttle,(unknown),Michael Cory,David D. McKee	46
18	Torsional effects in glycoside reactivity: saccharide couplings mediated by acetal protecting groups 1991 ·Journal of the American Chemical Society ·Bert Fraser‐Reid,Zufan Wu,C. Webster Andrews,Evan W. Skowronski,J. Phillip Bowen	169
19	HMQC‐NOESY: Application to a polynuclear aromatic at natural abundance 1990 ·Magnetic Resonance in Chemistry ·Ronald Ronald,(unknown),C. Webster Andrews,Gary E. Martin,(unknown),Raymond N. Castle	7
20	Novel carbohydrate transformations discovered en route to natural products 1989 ·Pure and Applied Chemistry ·Bert Fraser‐Reid,David R. Mootoo,Peter Konradsson,Uko E. Udodong,C. Webster Andrews,Andrew J. Ratcliffe,Zufan Wu,Kai Yu	8

About C. Webster Andrews

C. Webster Andrews is a scholar working on Virology, Organic Chemistry and Infectious Diseases, having authored 33 papers that have together received 2.7k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (8 papers), Carbohydrate Chemistry and Synthesis (7 papers) and Enzyme Catalysis and Immobilization (5 papers). The work is most often cited by research in Computational Theory and Mathematics (1.0k citations), Virology (182 citations) and Organic Chemistry (1.0k citations). C. Webster Andrews has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Bert Fraser‐Reid, J. Phillip Bowen, Mika Lindvall, Martha S. Head, Brian Clarke, Gregory L. Warren, Catherine E. Peishoff, Giovanna Tedesco, James M. Woolven and Ian D. Wall. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact